PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $184,000 | -70.5% | 58,463 | -72.8% | 0.00% | – |
| Q2 2020 | $624,000 | +543.3% | 214,559 | +375.7% | 0.00% | – |
| Q3 2019 | $97,000 | -53.6% | 45,103 | -32.3% | 0.00% | – |
| Q2 2019 | $209,000 | +31.4% | 66,664 | +56.4% | 0.00% | – |
| Q1 2019 | $159,000 | +160.7% | 42,635 | +103.8% | 0.00% | – |
| Q4 2018 | $61,000 | -9.0% | 20,917 | -17.8% | 0.00% | – |
| Q3 2018 | $67,000 | -14.1% | 25,434 | -4.6% | 0.00% | – |
| Q1 2018 | $78,000 | -45.1% | 26,652 | -48.7% | 0.00% | – |
| Q4 2017 | $142,000 | +208.7% | 51,972 | +279.1% | 0.00% | – |
| Q1 2016 | $46,000 | -80.7% | 13,709 | -71.1% | 0.00% | -100.0% |
| Q3 2015 | $238,000 | +36.0% | 47,409 | +90.6% | 0.00% | 0.0% |
| Q1 2015 | $175,000 | -23.9% | 24,875 | -16.5% | 0.00% | -50.0% |
| Q4 2014 | $230,000 | -58.4% | 29,804 | -59.7% | 0.00% | -66.7% |
| Q3 2014 | $553,000 | +453.0% | 74,031 | +512.5% | 0.01% | +500.0% |
| Q1 2014 | $100,000 | – | 12,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |